Some musings on IT (I.T. not ‘it’)

Over this weekend most British Airway’s flights were cancelled because of an IT problem. A couple of weeks ago part of the NHS was paralysed because of ransomware infecting their IT systems. It all goes to show how reliant we have become on something that wasn’t even a subject when I was at school. You probably have more computing power in your mobile phone than the Apollo astronauts had when then journeyed to the moon (and back). Continue reading “Some musings on IT (I.T. not ‘it’)”

Advertisements

My platelets are better than yours

I saw a haematology consultant today and the good news is that my platelet count has continued to rise. It is now 116 which is still below the normal level of 150 plus but is heading in the right direction. If you look at a graph of my platelet scores there is a clear upward trend from the panic inducing level of 10 in September. Continue reading “My platelets are better than yours”

Fine tuning the PSA sledgehammer

San Diego Dan has posted a link to an interesting article on various approaches to refining the PSA test. As I said a while ago a raised PSA really only shouts “Have more tests” since it is possible to have prostate cancer with a PSA of zero and to not have it with a PSA of 4,000. Factors such as how much time you spend on the saddle of a bicycle will have an impact on your PSA level. Then there is the question of whether the cancer is aggressive or not. If you can tell this then a lot of unnecessary treatment can be avoided. While I wouldn’t say avoid hospitals and treatment at all costs (and in the US personal costs can be significant) certainly if unnecessary treatments can be avoided not only does it save money it also avoids all the various side effects and risks associated with any medical intervention. The article explains that researchers are developing genetic tests, imaging tests, and algorithms in an effort to reduce the more than a million men a year who have prostate biopsies and, even more important, reduce the thousands who get treatment they don’t need.

https://www.statnews.com/2017/05/04/prostate-cancer-research-psa/